|
|
 |
|
News/Event Item
Stopping Tuberculosis: African Researchers Lead the Search for New TB Vaccines
Nov. 17, 2009
December 9, 2009
Capitol Hill
Washington, D.C.
One-third of the world's population is infected with the bacterium that causes tuberculosis, and 1.8 million people die each year from the disease. Co-infection with HIV/AIDS and the rise of drug-resistant strains of TB make this ancient killer a serious global threat today. TB is the leading cause of death in people living with HIV/AIDS in Africa and Asia; extensively drug-resistant TB (XDR-TB) has been detected in the United States and at least 54 other countries to date. New vaccines, drugs and diagnostics will be critical to curbing this terrible pandemic.
There is hope. Groundbreaking research is underway worldwide to develop safe, effective and affordable vaccines against all forms of TB in people of all ages, including people living with HIV. Researchers in Africa and elsewhere are leading the fight, harnessing the latest biomedical breakthroughs to accelerate the development of new vaccines to save lives in their communities and around the globe.
The Global Health Council and Aeras Global TB Vaccine Foundation held a panel discussion with scientists from Kenya, South Africa and Uganda, who described the clinical trials they are coordinating.
Featured Speakers:
- Dr. Sizulu Moyo, Clinical Researcher, South African Tuberculosis Vaccine Initiative
- Dr. Videlis Nduba, Principal Investigator, Kenya Medical Research Institute
- Dr. Harriet Mayanja-Kizza, Professor of Medicine, Makerere University (Uganda)
Moderator: Smita Baruah, Director of Government Relations, Global Health Council
View speaker presentations (accessible by members only)
View a ONE Campaign blog about this event:
http://www.one.org/blog/2009/12/09/front-lines-in-the-fight-against-tuberculosis/
category: Global Health Council News : Advocacy Events
contributed by Liza Nanni on 2 December 2009
North America :
recall this item.
|
|
Share
